Cargando…

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles

The HIV-1 envelope glycoprotein (Env) is present on the surface of the virion at a very low density compared to most other enveloped viruses. Substitution of various parts of the stalk domain of Env (gp41) with the corresponding elements from other viral glycoproteins has been shown to increase Env...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chapman, Rosamund, van Diepen, Michiel, Galant, Shireen, Kruse, Elizabeth, Margolin, Emmanuel, Ximba, Phindile, Hermanus, Tandile, Moore, Penny, Douglass, Nicola, Williamson, Anna-Lise, Rybicki, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158678/ https://www.ncbi.nlm.nih.gov/pubmed/32013223 http://dx.doi.org/10.3390/vaccines8010054

Ejemplares similares

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Chapman, Ros, et al.
Publicado: (2021)

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256
por: van Diepen, Michiel T., et al.
Publicado: (2018)

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens
por: Margolin, Emmanuel, et al.
Publicado: (2019)

Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus
por: van Diepen, Michiel T., et al.
Publicado: (2019)

Characterization and Immunogenicity of HIV Envelope gp140 Zera(®) Tagged Antigens
por: Ximba, Phindile, et al.
Publicado: (2020)

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines
por: Chapman, Rosamund, et al.
Publicado: (2023)

Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana
por: Margolin, Emmanuel, et al.
Publicado: (2021)

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector
por: van Diepen, Michiel, et al.
Publicado: (2021)

Augmenting glycosylation‐directed folding pathways enhances the fidelity of HIV Env immunogen production in plants
por: Margolin, Emmanuel, et al.
Publicado: (2022)

Stability studies of HIV-1 Pr55(gag) virus-like particles made in insect cells after storage in various formulation media
por: Lynch, Alisson, et al.
Publicado: (2012)

The thermodynamics of Pr55(Gag)-RNA interaction regulate the assembly of HIV
por: Tanwar, Hanumant S., et al.
Publicado: (2017)

Class II Transactivator (CIITA) Enhances Cytoplasmic Processing of HIV-1 Pr55Gag
por: Porter, Kristen A., et al.
Publicado: (2010)

Structural maturation of the HIV-1 RNA 5’ untranslated region by Pr55(Gag) and its maturation products
por: Gilmer, Orian, et al.
Publicado: (2022)

Characterization of a Novel Chimeric Theileria parva p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice
por: Whittle, Leah, et al.
Publicado: (2022)

Expression, purification, and functional characterization of soluble recombinant full-length simian immunodeficiency virus (SIV) Pr55(Gag)
por: Pillai, Vineeta N., et al.
Publicado: (2023)

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa
por: Margolin, Emmanuel, et al.
Publicado: (2020)

The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen
por: Chapman, Rosamund, et al.
Publicado: (2014)

The host protein Staufen1 interacts with the Pr55(Gag )zinc fingers and regulates HIV-1 assembly via its N-terminus
por: Chatel-Chaix, Laurent, et al.
Publicado: (2008)

LAMP-1 Chimeric to HIV-1 p55Gag in the Immunization of Neonate Mice Induces an Early Germinal Center Formation and AID Expression
por: Teixeira, Franciane Mouradian Emidio, et al.
Publicado: (2022)

Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing
por: Hakata, Yoshiyuki, et al.
Publicado: (2019)

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

CERN Opendays 2019 - PR-55
por: Chrul, Anna, et al.
Publicado: (2019)

HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies
por: Sheward, Daniel J., et al.
Publicado: (2022)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
por: Valley-Omar, Ziyaad, et al.
Publicado: (2011)

Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
por: Chapman, Rosamund, et al.
Publicado: (2013)

Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55(Gag) with the phospholipase C-δ1 pleckstrin homology domain results in infectious pseudovirion production
por: Urano, Emiko, et al.
Publicado: (2008)

IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag
por: Ahi, Yadvinder S., et al.
Publicado: (2020)

Correction: Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
por: Chapman, Rosamund, et al.
Publicado: (2013)

Development of a dual vaccine against East Coast fever and lumpy skin disease
por: Whittle, Leah, et al.
Publicado: (2023)

New insights into retroviral Gag–Gag and Gag–membrane interactions
por: Maldonado, José O., et al.
Publicado: (2014)

Evidence that Vpu Modulates HIV-1 Gag-Envelope Interaction towards Envelope Incorporation and Infectivity in a Cell Type Dependent Manner
por: Gautam, Archana, et al.
Publicado: (2013)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
por: Murji, Amyn A., et al.
Publicado: (2021)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice
por: Chapman, Ros, et al.
Publicado: (2017)

Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients
por: Sakkhachornphop, Supachai, et al.
Publicado: (2018)

Gag-Gag Interactions Are Insufficient to Fully Stabilize and Order the Immature HIV Gag Lattice
por: Saha, Ipsita, et al.
Publicado: (2021)

HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice
por: Jongwe, Tsungai Ivai, et al.
Publicado: (2016)

Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production
por: Lynch, Alisson G, et al.
Publicado: (2010)

Gag-Vpu cross talk modulating HIV-1 envelope incorporation and infectivity in cell-type dependent manner
por: Gautam, Archana, et al.
Publicado: (2012)

Expression, purification, and characterization of biologically active full-length Mason-Pfizer monkey virus (MPMV) Pr78(Gag)
por: Pitchai, Fathima Nuzra Nagoor, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hfuchv7oalsopnu464bv73vin3